Company Profile

ICET Inc (AKA: Innovative Chemical Technologies~Innovative Chemical and Environmental Technolog)
Profile last edited on: 5/27/2021      CAGE: 0UDU2      UEI: JF7VN7UHFLM5

Business Identifier: Energy, environment, and biomedicine technologies
Year Founded
1990
First Award
1990
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

916 Pleasant Street Unit 12
Norwood, MA 02062
   (781) 769-6064
   shantha@icetinc.com
   www.icetinc.com
Location: Single
Congr. District: 08
County: Norfolk

Public Profile

Previously known as Innovative Chemical Technologies and as Innovative Chemical/Environmental Technologies, ICET, Inc. is an R&D company developing technologies in the areas of energy, environment, and biomedicine. ICET's major strength is in electrochemistry, catalysis, and surface modification of polymers and inorganic materials. With biocompatible, antimicrobial and anticalicifaction characteristics, this a platform technology relevant for use in a large array of medical devices. Comparative multidrug resistant in vitro bacterial challenge tests of a coated catheter shows distinct superiority over the two existing products. The preclinical evaluation of a certain device was found to be promising. Preliminary safety biocompatibility tests have been successfully completed.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $674,710
Project Title: UTI Reduction in Neurogenic Bladder
2020 1 NIH $99,993
Project Title: A Topical Nasal Gel as an Invisible Shield Against Viral and Bacterial Pathogens
2013 1 NIH $149,753
Project Title: An In Situ Opioid Drug Deactivation Kit For Home Use
2013 1 NIH $141,561
Project Title: Kidney Stone Inhibitors
2013 1 CBD $99,963
Project Title: Self-Healing Shape Memory Polymer Coatings for Chemical/Biological Protective Clothing

Key People / Management

  Shantha S Sarangapani -- President

  Michael McCarthy -- Vice President, Commercial Business Development

  Sarang Sarangapani -- Executive VP

Company News

There are no news available.